UNVC: In reference to the 1.283.173.150 exempt shares being
UNVC: In reference to the 1.283.173.150 exempt shares being added to the open market float, there was 119. 949.387 shares added to the float with the exempt shares. Total of 1.403.122.537.
I talked with Michael at
Customer Communications Manager
P: 800.509.5586 E: cstmail@continentalstock.com A: 1 State Street 30th Floor
New York, NY 10004-156 W: www.continentalstock.com
They do not provide information regarding a specific shareholder's account to anyone. They do not require SEC council to remove the legend, it is a matter solely in the discretion of the issuer of the securities. State law, not federal law, the SEC doesn't even get involved if there is a dispute.
Rule 144 under the Securities Act of 1933 provides the most commonly used exemption for holders to sell restricted securities. To take advantage of this rule, you must meet several conditions, including a six-month or one-year holding period
The CONDITIONS for EXEMPTION were met for them the day he got them.
This is what it would look like if they weren't exempt from the very beginning.
From a Securities Attorney who helps get the legend removed from shareholders of restricted shares this is basically what MLR posted, he can make a joke of it and claim I twisted words all he wants these are just the facts.
It doesn't matter what I believe this just all facts. Anyone else can believe anything they want that's their privilege to do so.
Daltons are exempt from any regulatory filings; all he had to do was get the legend removed. They doubled the float and he can sell any anytime at his discretion. Plus, he's also got the 119.949.387 shares to sell.
Securities Attorney
If you are eligible to sell your shares, the law firm will issue the appropriate opinion letter, deliver the opinion letter and attachments to your broker and send a copy of the opinion letter and attachments to the Company that issued the shares to you for review.
Your broker will send the opinion and attachments, the original certificate(s) and stock power(s), a check for the fees of the Company’s stock transfer agent and a letter of instruction to the stock transfer agent.
The stock transfer agent will contact the issuer of the securities and ask if there is any lawful reason why the Rule 144 legend should not be removed. The issuer must consent to the removal unless there are factual or legal reasons why the legend should not be removed. There are state laws that must be followed. Any issuer or transfer agent that ignores these laws and refuses to remove the restrictive legend is subject to substantial liability.
Assuming that there are no valid reasons why the Rule 144 legend should not be removed, the issuer will inform the stock transfer agent that the restrictive legend may be removed. The stock transfer agent will return the cleared shares to your broker by the method requested by the broker. Your broker may then sell the number of shares that you have authorized to be sold.
4
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...
Continue Reading
Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...
Continue Reading
Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...
Continue Reading
Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...
Continue Reading
The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...
Continue Reading
Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...
Continue Reading
Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...
Continue Reading
A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...
Continue Reading
Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...
Continue Reading
Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...
Continue Reading
Top 5 Most Recently Viewed Articles
Renault Group's Growth in Q3 2024: A Closer Look Renault Group has recently announced its revenue results for the third quarter of 2024, showcasing a commendable 5.0% growth at constant exchange rates. With an impressive revenue of €10.7 billion, this growth signals a positive trajectory for the company as it navigates through a transforming automotive landscape....
Continue Reading
Revolutionizing Risk Assessment in Multiple Myeloma Understanding the complexities of multiple myeloma is vital for developing effective treatment strategies. Historically, high-risk multiple myeloma patients have needed the most intensive treatment protocols, but definitions of high risk can vary due to the heterogeneity of clinical markers and staging systems. This...
Continue Reading
FlexShopper Makes Strategic Moves for Shareholder Value FlexShopper, Inc. (NASDAQ: FPAY), a prominent player in the online lease-to-own retail and payment solutions landscape, has recently made headlines by entering into a purchase option agreement with the primary holder of its Series 2 Preferred Stock. This option allows FlexShopper to redeem an impressive 91% of its...
Continue Reading
Investor Alert: Class Action Lawsuit Involving Extreme Networks, Inc. There's an important update for shareholders of Extreme Networks, Inc. (NASDAQ: EXTR). Investors are encouraged to take steps regarding their rights in relation to an ongoing class action lawsuit. ClaimsFiler, an organization dedicated to helping retail investors, emphasizes the importance for affected...
Continue Reading
GBI Biomanufacturing Welcomes New Leadership GBI Biomanufacturing has made a significant announcement regarding its leadership, introducing Jesse McCool, Ph.D. as the newly appointed President. This move is a pivotal moment for GBI, a dedicated company in the biopharmaceutical sector, known for providing integrated development and manufacturing services for biologics....
Continue Reading